JPRN-UMIN000028758Completed未知
Amyloid PET imaging study for dimenting disorders - Amyloid PET imaging study for dimenting disorders
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama0 sites20 target enrollmentStarted: September 19, 2017Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 20
Study Overview
Brief Summary
unpublished
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •delirium, depression,paranoia, drug-induced dementia state
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Research for Amyloid PET-MRIHealthy volunteer, Alzheimer's disease, Mild cognitive impairment, Parkinson's disease, PDJPRN-UMIN000040338Kyoto University160
Active, not recruiting
Phase 1
oneFocal dementia syndromes - primary aphasiaMedDRA version: 14.1 Level: LLT Classification code 10012292 Term: Dementia of the Alzheimer's type NOS System Organ Class: 10029205 - Nervous system disordersEUCTR2010-023852-10-GBAvid Radiopharmaceuticals, Inc.23
Active, not recruiting
Phase 1
Amyloid Imaging with [11C]PIB PET and MRI in MCI – a pilot study - MCI and PIBEUCTR2010-020724-21-ATniversitätsklinik für Neurologie, Medizinische Universität Wien
Completed
Not Applicable
Studies on the amyloid PET imaging in patients with dementiapatients with dementiaJPRN-UMIN000010767Mie University Graduate School of Medicine30
Completed
Not Applicable
Evaluation of Amyloid Imaging in Patients with Parkinson's diseaseParkinson diseaseJPRN-UMIN000018035Department of Neurology, Keio University School of Medicine100